New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on September 19, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co, has recently sold 106,626 shares of the company’s stock. This transaction amounts to a substantial $81,531,452.
Spark’s Take on LLY Stock
According to Spark, TipRanks’ AI Analyst, LLY is a Outperform.
Eli Lilly & Co’s overall stock score reflects strong financial performance and positive earnings call highlights, including significant revenue and earnings growth. However, high valuation and leverage, along with moderate technical indicators, temper the overall outlook. Strategic investments and product successes provide a cautiously optimistic future, despite some market challenges.
To see Spark’s full report on LLY stock, click here.
More about Eli Lilly & Co
YTD Price Performance: -0.58%
Average Trading Volume: 4,419,075
Technical Sentiment Signal: Buy
Current Market Cap: $719.4B